Sample A: Cover Page of Thesis, Project, or Dissertation Proposal

27. Bai J, Cederbaum AI: Catalase protects HepG2 cells from apoptosis induced by
DNA-damaging agents by accelerating the degradation of p53. J Biol Chem 2003,
278(7):4660-4667.
28. Kondo T, Kitano T, Iwai K, Watanabe M, Taguchi Y, Yabu T, Umehara H, Domae N,
Uchiyama T, Okazaki T: Control of ceramide-induced apoptosis by IGF-1:
involvement of PI-3 kinase, caspase-3 and catalase. Cell Death Differ 2002, 9(6):682-
692.
29. Oshiro MM, Futscher BW, Lisberg A, Wozniak RJ, Klimecki WT, Domann FE, Cress
AE: Epigenetic regulation of the cell type-specific gene 14-3-3sigma. Neoplasia 2005,
7(9):799-808.
30. Yang HY, Wen YY, Chen CH, Lozano G, Lee MH: 14-3-3 sigma positively regulates
p53 and suppresses tumor growth. Mol Cell Biol 2003, 23(20):7096-7107.
31. Zhang Y, Karas M, Zhao H, Yakar S, LeRoith D: 14-3-3sigma mediation of cell cycle
progression is p53-independent in response to insulin-like growth factor-I receptor
activation. J Biol Chem 2004, 279(33):34353-34360.
32. Dubois T, Paleotti O, Mironov AA, Fraisier V, Stradal TE, De Matteis MA, Franco M,
Chavrier P: Golgi-localized GAP for Cdc42 functions downstream of ARF1 to
control Arp2/3 complex and F-actin dynamics. Nat Cell Biol 2005, 7(4):353-364.
33. Kaneda A, Kaminishi M, Sugimura T, Ushijima T: Decreased expression of the seven
ARP2/3 complex genes in human gastric cancers. Cancer Lett 2004, 212(2):203-210.
34. Taira K, Umikawa M, Takei K, Myagmar BE, Shinzato M, Machida N, Uezato H,
Nonaka S, Kariya K: The Traf2- and Nck-interacting kinase as a putative effector of
Rap2 to regulate actin cytoskeleton. J Biol Chem 2004, 279(47):49488-49496.
35. Heale JT, Ball AR, Jr., Schmiesing JA, Kim JS, Kong X, Zhou S, Hudson DF, Earnshaw
WC, Yokomori K: Condensin I interacts with the PARP-1-XRCC1 complex and
functions in DNA single-strand break repair. Mol Cell 2006, 21(6):837-848.
36. Maeda Y, Hunter TC, Loudy DE, Dave V, Schreiber V, Whitsett JA: PARP-2 interacts
with TTF-1 and regulates expression of surfactant protein-B. J Biol Chem 2006,
281(14):9600-9606.
37. Brasch F, Johnen G, Winn-Brasch A, Guttentag SH, Schmiedl A, Kapp N, Suzuki Y,
Muller KM, Richter J, Hawgood S et al: Surfactant protein B in type II pneumocytes
and intra-alveolar surfactant forms of human lungs. Am J Respir Cell Mol Biol 2004,
30(4):449-458.
38. Das A, Boggaram V: Proteasome dysfunction inhibits surfactant protein gene
expression in lung epithelial cells: mechanism of inhibition of SP-B gene expression.
Am J Physiol Lung Cell Mol Physiol 2007, 292(1):L74-84.
169